Oncology

Latest News

Based on results from the phase 2 KEYNOTE-158, KEYNOTE-164, and KEYNOTE-051 trials, the FDA has given full approval to pembrolizumab for patients with microsatellite instability-high or mismatch repair deficient solid tumors.
FDA Gives Full Approval to Pembrolizumab in dMMR/MSI-H Solid Tumors

March 29th 2023

Based on results from the phase 2 KEYNOTE-158, KEYNOTE-164, and KEYNOTE-051 trials, the FDA has given full approval to pembrolizumab for patients with microsatellite instability-high or mismatch repair deficient solid tumors.

Data from a prospective pilot study indicate that circulating tumor DNA may be a valuable prognostic biomarker in early-stage follicular lymphoma.
Basal ctDNA May Predict Treatment Outcomes in Follicular Lymphoma

March 9th 2023

The safety profile of fam-trastuzumab deruxtecan-nxki for managing HER2-expressing tumors in the DESTINY-PanTumor02 trial appears consistent with previously reported findings on the agent.
Fam-Trastuzumab Deruxtecan-nxki Yields Durable Responses in HER2+ Tumors

March 7th 2023

Findings from the phase 3 DeFi trial support the new drug application for nirogacestat as a treatment for adults with desmoid tumors.
FDA Grants Priority Review to Nirogacestat for Desmoid Tumors

February 27th 2023

Adverse effects including light sensitivity and blurred vision lead to a clinical hold on enrollment for the phase 1/2 VERA trial evaluating BLU-222 in advanced solid tumors.
FDA Pauses Trial Investigating BLU-222 in Advanced Solid Tumors

February 17th 2023

Latest CME Events & Activities

Leukemia Therapy – A Look Into the Future

View More

Community Practice Connections™: Pathology Oncology Collaborative: Biomarker Testing in an Emerging Era of HER2 Across Breast, GI, and Lung Cancers

View More

Clinical Interchange™: Improving Outcomes and Overcoming Barriers to Equitable Care in African American Patients With Multiple Myeloma

View More

Oncology Town Hall™: Primary Investigators Present Key Abstracts in Gastrointestinal Malignancies from Paris

View More

2nd Annual Virtual Tumor Board®: Integrating Emerging Testing Methodologies into Optimal Treatment Planning in Gastrointestinal Cancers

View More

Community Practice Connections™: 19th Annual Meeting of the International Society of Gastrointestinal Oncology®

View More

Community Practice Connections™: 4th annual Precision Medicine Symposium: An Illustrated Tumor Board

View More

Optimizing Pain Management for Breast Cancer Surgery Patients in the Age of the Opioid Epidemic

View More

41st Annual Miami Breast Cancer Conference®

View More

From Trials to the Real World: Assessing the Role of Allogeneic Transplant and JAK Inhibitors as Treatment Paradigms Evolve in Myelofibrosis

View More

Medical Crossfire®: How Does the Evidence Inform Your RCC Sequence? The Experts Share Clinical Perspectives

View More

Oncology On-Call®: The Experts’ Take on How Sea Changes in GvHD Prophylaxis and Management Can Be Practically Implemented in Your Clinic

View More

Oncology On-Call®: The Experts’ Take on How Sea Changes in GvHD Prophylaxis and Management Can Be Practically Implemented in Your Clinic

View More

Community Practice Connections™: Matching the Tumor With Patient-Specific Goals to Inform Frontline Selection and Sequencing in Chronic Lymphocytic Leukemia

View More

Community Practice Connections™: MRD Assessment as a Cornerstone to Clinical Decision-Making in Hematologic Malignancies: Techniques, Utilization, and Best Practices to Optimize Patient Outcomes

View More

Community Practice Connections™: State-of-the-Art CMV Care: Experts’ Perspectives on Primary/Secondary Prevention and Management of Refractory/Resistant Infections

View More

Cancer Summaries and Commentaries™: Report from New Orleans on the Latest Updates in GvHD Prevention and Treatment

View More

Clinical Vignettes: Inaugural International Congress on Pediatric Oncology

View More

Expert Perspectives on Emerging CDK4/6 Inhibitor Strategies in Advanced Prostate Cancer Management Settings

View More

Community Practice Connections™: Maximizing Our Clinical Practices in Hodgkin Lymphoma: Integration of Recent Data Sets in Real World Settings

View More

20th Annual Meeting of the International Society of Gastrointestinal Oncology®

10/13/2023-10/14/2023

View More

Keeping Pace with Rapid Advancements in Multiple Myeloma Care

View More

Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes

View More

Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes

View More

22nd Annual International Congress on the Future of Breast Cancer® West

07/28/2023 - 07/29/2023

View More

Clinical Vignettes: 40th Annual CFS®: Innovative Cancer Therapy for Tomorrow®

View More

Community Practice Connections™: Multidisciplinary Management of BPDCN: Strategies for Differential Diagnosis and Integrating Novel Targeted Therapy

View More

Oncology Consultations®: Determining Treatment-Related Adverse Events from Disease Progression Along the MPN Care Continuum

View More

Trekking Through the Latest Updates for ROS1-Targeted Therapies

View More

Community Practice Connections™: 6th Annual Precision Medicine Through Plasma™ – Using Liquid Biopsies in Contemporary Oncology Care

View More